Skip to content
healthcare.dev

Bumetanide

NDC 67184-0593, Bumetanide, injection, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0593
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
INJECTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219116
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0593 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUMETANIDE.25 mg/mL

Pharmacologic classes

Increased Diuresis at Loop of Henle [PE]; Loop Diuretic [EPC]

Package NDCNDC-11Package
67184-0593-26718405930210 VIAL in 1 CARTON (67184-0593-2) / 4 mL in 1 VIAL (67184-0593-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ef5fe12a-f8ee-4ba7-932b-51bbaccf6575

Use it

Look up 67184-0593 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0593 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0593. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.